1. Home
  2. IMAB vs PHUN Comparison

IMAB vs PHUN Comparison

Compare IMAB & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • PHUN
  • Stock Information
  • Founded
  • IMAB 2014
  • PHUN 2009
  • Country
  • IMAB United States
  • PHUN United States
  • Employees
  • IMAB N/A
  • PHUN N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • PHUN EDP Services
  • Sector
  • IMAB Health Care
  • PHUN Technology
  • Exchange
  • IMAB Nasdaq
  • PHUN Nasdaq
  • Market Cap
  • IMAB 79.9M
  • PHUN 88.8M
  • IPO Year
  • IMAB 2020
  • PHUN N/A
  • Fundamental
  • Price
  • IMAB $0.96
  • PHUN $3.86
  • Analyst Decision
  • IMAB Strong Buy
  • PHUN Strong Buy
  • Analyst Count
  • IMAB 3
  • PHUN 3
  • Target Price
  • IMAB $8.00
  • PHUN $13.00
  • AVG Volume (30 Days)
  • IMAB 286.0K
  • PHUN 879.4K
  • Earning Date
  • IMAB 03-13-2025
  • PHUN 03-11-2025
  • Dividend Yield
  • IMAB N/A
  • PHUN N/A
  • EPS Growth
  • IMAB N/A
  • PHUN N/A
  • EPS
  • IMAB N/A
  • PHUN N/A
  • Revenue
  • IMAB $569,464.00
  • PHUN $3,537,000.00
  • Revenue This Year
  • IMAB N/A
  • PHUN N/A
  • Revenue Next Year
  • IMAB N/A
  • PHUN $93.33
  • P/E Ratio
  • IMAB N/A
  • PHUN N/A
  • Revenue Growth
  • IMAB N/A
  • PHUN N/A
  • 52 Week Low
  • IMAB $0.84
  • PHUN $2.85
  • 52 Week High
  • IMAB $2.00
  • PHUN $17.99
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 45.33
  • PHUN 40.99
  • Support Level
  • IMAB $0.95
  • PHUN $3.56
  • Resistance Level
  • IMAB $1.04
  • PHUN $4.04
  • Average True Range (ATR)
  • IMAB 0.06
  • PHUN 0.20
  • MACD
  • IMAB -0.01
  • PHUN 0.01
  • Stochastic Oscillator
  • IMAB 19.88
  • PHUN 51.72

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About PHUN Phunware Inc.

Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States.

Share on Social Networks: